Point72 Hong Kong’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-101
Closed -$3K 2427
2021
Q4
$3K Sell
101
-2,640
-96% -$75.5K ﹤0.01% 1768
2021
Q3
$59K Buy
2,741
+735
+37% +$17.7K ﹤0.01% 1485
2021
Q2
$51K Buy
2,006
+503
+33% +$10.7K ﹤0.01% 1468
2021
Q1
$27K Buy
+1,503
New +$25K ﹤0.01% 1417
2020
Q1
Sell
-892
Closed -$7K 1434
2019
Q4
$7K Buy
+892
New +$5.21K ﹤0.01% 1026
2019
Q1
Sell
-459
Closed -$2K 1332
2018
Q4
$2K Buy
+459
New +$2.4K ﹤0.01% 761

Other funds holding CDMO

Point72 Hong Kong's CDMO Position: Q1 2022 in Review

Point72 Hong Kong sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 101 shares — an estimated $3K sold.

Point72 Hong Kong first reported a position in CDMO in Q4 2018 and held it in 6 quarters. The position peaked at $59K in Q3 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • Point72 Hong Kong reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 101 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $3K.
  • Point72 Hong Kong first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
  • Point72 Hong Kong's Avid Bioservices, Inc. Common Stock position peaked at $59K in Q3 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.